APA (7th ed.) Citation

R, R., M, R., F, I., V, C., A, d. I., M, G., . . . B, P. (2026). Are glutathionylated aldehyde reductases the missing piece of the "catecholaldehyde hypothesis" in Parkinson's disease? A medical hypothesis concerning the detoxification of 4-hydroxynonenal (HNE) and 3,4-dihydroxyphenylacetaldehyde (DOPAL). Redox biology, 90, 104060. https://doi.org/10.1016/j.redox.2026.104060

Chicago Style (17th ed.) Citation

R, Rotondo, et al. "Are Glutathionylated Aldehyde Reductases the Missing Piece of the "Catecholaldehyde Hypothesis" in Parkinson's Disease? A Medical Hypothesis Concerning the Detoxification of 4-hydroxynonenal (HNE) and 3,4-dihydroxyphenylacetaldehyde (DOPAL)." Redox Biology 90 (2026): 104060. https://doi.org/10.1016/j.redox.2026.104060.

MLA (9th ed.) Citation

R, Rotondo, et al. "Are Glutathionylated Aldehyde Reductases the Missing Piece of the "Catecholaldehyde Hypothesis" in Parkinson's Disease? A Medical Hypothesis Concerning the Detoxification of 4-hydroxynonenal (HNE) and 3,4-dihydroxyphenylacetaldehyde (DOPAL)." Redox Biology, vol. 90, 2026, p. 104060, https://doi.org/10.1016/j.redox.2026.104060.